JP2013531684A5 - - Google Patents

Download PDF

Info

Publication number
JP2013531684A5
JP2013531684A5 JP2013519035A JP2013519035A JP2013531684A5 JP 2013531684 A5 JP2013531684 A5 JP 2013531684A5 JP 2013519035 A JP2013519035 A JP 2013519035A JP 2013519035 A JP2013519035 A JP 2013519035A JP 2013531684 A5 JP2013531684 A5 JP 2013531684A5
Authority
JP
Japan
Prior art keywords
phenyl
imidazo
pyridin
cyclobutylamine
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013519035A
Other languages
English (en)
Japanese (ja)
Other versions
JP5830094B2 (ja
JP2013531684A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2011/061508 external-priority patent/WO2012007345A2/en
Publication of JP2013531684A publication Critical patent/JP2013531684A/ja
Publication of JP2013531684A5 publication Critical patent/JP2013531684A5/ja
Application granted granted Critical
Publication of JP5830094B2 publication Critical patent/JP5830094B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013519035A 2010-07-12 2011-07-07 置換イミダゾ[1,2−a]ピリミジンおよび−ピリジン Expired - Fee Related JP5830094B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP10169205.1 2010-07-12
EP10169205 2010-07-12
US39277910P 2010-10-13 2010-10-13
US61/392,779 2010-10-13
PCT/EP2011/061508 WO2012007345A2 (en) 2010-07-12 2011-07-07 Substituted imidazo[1,2-a]pyrimidines and -pyridines

Publications (3)

Publication Number Publication Date
JP2013531684A JP2013531684A (ja) 2013-08-08
JP2013531684A5 true JP2013531684A5 (enExample) 2014-08-21
JP5830094B2 JP5830094B2 (ja) 2015-12-09

Family

ID=44532777

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013519035A Expired - Fee Related JP5830094B2 (ja) 2010-07-12 2011-07-07 置換イミダゾ[1,2−a]ピリミジンおよび−ピリジン

Country Status (10)

Country Link
US (1) US8975265B2 (enExample)
EP (1) EP2593451B1 (enExample)
JP (1) JP5830094B2 (enExample)
CN (1) CN103097384B (enExample)
AR (1) AR090005A1 (enExample)
CA (1) CA2804845A1 (enExample)
ES (1) ES2552841T3 (enExample)
TW (1) TW201206933A (enExample)
UY (1) UY33503A (enExample)
WO (1) WO2012007345A2 (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112013025732B1 (pt) * 2011-04-06 2022-02-22 Taiho Pharmaceutical Co., Ltd Compostos de imizazo-oxazina, seus usos e composição farmacêutica e fármaco compreendendo os mesmos
JP5906303B2 (ja) 2011-04-07 2016-04-20 バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングBayer Intellectual Property GmbH Aktキナーゼ阻害剤としてのイミダゾピリダジン類
US9370517B2 (en) * 2012-01-10 2016-06-21 Bayer Intellectual Property Gmbh Substituted pyrazolopyrimidines as Akt kinase inhibitors
CN104066735B (zh) * 2012-01-10 2016-08-31 拜耳知识产权有限责任公司 作为akt激酶抑制剂的取代的咪唑并吡嗪
EP2872508B1 (en) * 2012-07-13 2018-08-29 UCB Biopharma SPRL Imidazopyridine derivatives as modulators of tnf activity
DK3105218T3 (da) 2014-02-13 2019-11-04 Incyte Corp Cyclopropylaminer som lsd1-inhibitorer
US9527835B2 (en) 2014-02-13 2016-12-27 Incyte Corporation Cyclopropylamines as LSD1 inhibitors
TWI720451B (zh) 2014-02-13 2021-03-01 美商英塞特控股公司 作為lsd1抑制劑之環丙胺
TW201613860A (en) 2014-02-13 2016-04-16 Incyte Corp Cyclopropylamines as LSD1 inhibitors
KR102359214B1 (ko) 2014-04-04 2022-02-07 델 마 파마슈티컬스 폐의 비소세포 암종 및 난소암을 치료하기 위한 디안하이드로갈락티톨 및 이의 유사체 또는 유도체
WO2016007736A1 (en) 2014-07-10 2016-01-14 Incyte Corporation Imidazopyrazines as lsd1 inhibitors
WO2016007722A1 (en) 2014-07-10 2016-01-14 Incyte Corporation Triazolopyridines and triazolopyrazines as lsd1 inhibitors
US9695168B2 (en) 2014-07-10 2017-07-04 Incyte Corporation Substituted imidazo[1,5-α]pyridines and imidazo[1,5-α]pyrazines as LSD1 inhibitors
WO2016007727A1 (en) 2014-07-10 2016-01-14 Incyte Corporation Triazolopyridines and triazolopyrazines as lsd1 inhibitors
HK1245794A1 (zh) 2015-02-27 2018-08-31 大鹏药品工业株式会社 咪唑并恶嗪晶体、含有所述晶体的药物组合物和制备所述晶体的方法
PE20180455A1 (es) 2015-04-03 2018-03-05 Incyte Corp Compuestos heterociclicos como inhibidores de lsd1
CN106188063A (zh) * 2015-05-08 2016-12-07 中国科学院上海药物研究所 用作Lp-PLA2抑制剂的双环类化合物、其制备方法及医药用途
UA126277C2 (uk) 2015-08-12 2022-09-14 Інсайт Корпорейшн Солі інгібітору lsd1
US11883404B2 (en) 2016-03-04 2024-01-30 Taiho Pharmaceuticals Co., Ltd. Preparation and composition for treatment of malignant tumors
MA44725A (fr) 2016-04-22 2019-02-27 Incyte Corp Formulations d'un inhibiteur de lsd1
US11352328B2 (en) 2016-07-12 2022-06-07 Arisan Therapeutics Inc. Heterocyclic compounds for the treatment of arenavirus
KR20190043437A (ko) 2017-10-18 2019-04-26 씨제이헬스케어 주식회사 단백질 키나제 억제제로서의 헤테로고리 화합물
GB201811695D0 (en) * 2018-07-17 2018-08-29 Salvensis Compounds for use in the treatment of fascioliasis
WO2020047198A1 (en) 2018-08-31 2020-03-05 Incyte Corporation Salts of an lsd1 inhibitor and processes for preparing the same
KR102195348B1 (ko) 2018-11-15 2020-12-24 에이치케이이노엔 주식회사 단백질 키나제 억제제로서의 신규 화합물 및 이를 포함하는 약제학적 조성물
US12419865B2 (en) 2018-12-06 2025-09-23 Arisan Therapeutics Inc. Compounds for the treatment of arenavirus infection
CN109734713B (zh) * 2019-03-07 2021-06-04 东华理工大学 一种3-亚胺基咪唑并[1,2-a]吡啶化合物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100959771B1 (ko) * 2005-06-10 2010-05-28 머크 샤프 앤드 돔 코포레이션 Akt 활성의 억제제
AR064010A1 (es) 2006-12-06 2009-03-04 Merck & Co Inc Inhibidores de la actividad de la akt
EP2176259B1 (en) 2007-08-14 2011-03-30 Bayer Schering Pharma Aktiengesellschaft Fused imidazoles for cancer treatment
BRPI0908906A2 (pt) 2008-03-21 2019-09-24 Novartis Ag compostos heterocíclicos e usos dos mesmos
AU2009255358A1 (en) 2008-06-03 2009-12-10 Msd K.K. Inhibitors of Akt activity
WO2010088177A1 (en) 2009-02-02 2010-08-05 Merck Sharp & Dohme Corp. Inhibitors of akt activity
WO2010104705A1 (en) 2009-03-12 2010-09-16 Merck Sharp & Dohme Corp. Inhibitors of akt activity
EP2413932A4 (en) 2009-04-01 2012-09-19 Merck Sharp & Dohme HAMMER OF ACT ACTIVITY
US8546376B2 (en) 2009-09-18 2013-10-01 Almac Discovery Limited Pharmaceutical compounds
GB0919380D0 (en) 2009-11-04 2009-12-23 Almac Discovery Ltd Pharmaceutical compouds

Similar Documents

Publication Publication Date Title
JP2013531684A5 (enExample)
JP6770127B2 (ja) Btk阻害薬としての一級カルボキサミド類
US11485745B2 (en) Amido spirocyclic amide and sulfonamide derivatives
EP3630770B1 (en) Pyrazolo[3,4-b]pyrazine derivatives as shp2 phosphatase inhibitors
KR101959590B1 (ko) c-KIT 키나제 억제제로서의 화합물 및 조성물
JP6938737B2 (ja) 核内受容体調節剤
US20240245681A1 (en) Heterocyclic derivatives useful as shp2 inhibitors
TWI429434B (zh) 作為受體酪胺酸激酶抑制劑之咪唑并〔1,2-a〕吡啶化合物
AU2009278442B2 (en) Imidazopyridin-2-one Derivatives
JP7654071B2 (ja) 複素環スピロ化合物及び使用方法
JP5830094B2 (ja) 置換イミダゾ[1,2−a]ピリミジンおよび−ピリジン
KR20080026654A (ko) 헤테로시클릭 야누스 키나제 3 억제제
TWI731317B (zh) 原肌球蛋白相關之激酶(trk)抑制劑
JP2010523576A5 (enExample)
MX2015004151A (es) Inhibidores del factor de diferenciacion de crecimiento-8 (gdf-8).
KR20170132323A (ko) 이미다졸로닐 퀴놀린 및 atm 키나아제 저해제로서의 이의 용도
KR20180030199A (ko) 콜로니 자극 인자-1 수용체(csf-1r) 저해제
CA3160307A1 (en) Substituted 1,5-naphthyridines or quinolines as alk5 inhibitors
JP7426486B2 (ja) インターフェロン遺伝子刺激因子(sting)のモジュレーターとしての複素環式化合物
JP2020502252A (ja) Dyrk1aおよび/またはdyrk1bキナーゼの阻害剤としてのキノリンの誘導体
CN114341125A (zh) Trex1调节剂
TW202233174A (zh) 肽基精胺酸去亞胺酶之抑制劑
WO2024226914A2 (en) Mrgprx2 antagonists and methods of use thereof
NZ734594A (en) Bicyclic heterocycles as fgfr4 inhibitors